Mary‐Ellen Taplin

Active 1995–2026

Also published as
Mary-Ellen Taplin · Mary Ellen Taplin
132
Papers
43,819
Citations
76
h-index
127
i10-index

Citations

Citations per year for Mary‐Ellen Taplin1896: 1 citations1994: 2 citations1995: 2 citations1996: 9 citations1997: 14 citations1998: 21 citations1999: 27 citations2000: 23 citations2001: 49 citations2002: 58 citations2003: 64 citations2004: 73 citations2005: 106 citations2006: 88 citations2007: 90 citations2008: 101 citations2009: 121 citations2010: 126 citations2011: 186 citations2012: 149 citations2013: 284 citations2014: 316 citations2015: 386 citations2016: 450 citations2017: 496 citations2018: 550 citations2019: 1,688 citations2020: 1,799 citations2021: 1,876 citations2022: 1,426 citations2023: 988 citations2024: 1,597 citations2025: 683 citations2026: 21 citations1897–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,413 citing papers, 29.2% of this breakdownChina: 1,163 citing papers, 7.7% of this breakdownUnited Kingdom: 1,079 citing papers, 7.1% of this breakdownCanada: 874 citing papers, 5.8% of this breakdownGermany: 732 citing papers, 4.8% of this breakdownItaly: 710 citing papers, 4.7% of this breakdownFrance: 582 citing papers, 3.9% of this breakdownAustralia: 525 citing papers, 3.5% of this breakdownSpain: 446 citing papers, 2.9% of this breakdownNetherlands: 408 citing papers, 2.7% of this breakdownJapan: 387 citing papers, 2.6% of this breakdownSwitzerland: 372 citing papers, 2.5% of this breakdown
0%29.2%Other 22.6%

Fields

  • Medicine69.5%
  • Biochemistry, Genetics and Molecular Biology25.6%
  • Immunology and Microbiology1.8%
  • Engineering0.5%
  • Computer Science0.5%
  • Agricultural and Biological Sciences0.3%
  • Other1.8%

Topics

  • Prostate Cancer Treatment and Research19.9%
  • Prostate Cancer Diagnosis and Treatment9.2%
  • Cancer Genomics and Diagnostics4.7%
  • Radiopharmaceutical Chemistry and Applications3.8%
  • Cancer, Lipids, and Metabolism3.2%
  • Cancer Immunotherapy and Biomarkers2.3%
  • Other56.9%

Coauthors

All papers

Open in search
  1. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 3,701

  2. Genomic correlates of clinical outcome in advanced prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce Montgomery, Himisha Beltran, Elisabeth I. Heath, Howard I. Scher, Philip W. Kantoff, Mary‐Ellen Taplin, Nikolaus Schultz, Johann S. de Bono, Francesca Demichelis, Peter S. Nelson, Mark A. Rubin, Arul M. Chinnaiyan, Charles L. Sawyers - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 1,408

  3. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 4,574

  4. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 cited by 1,603

  5. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Leeson, Rachel Barry, Joseph F. Kramkowski, Zhenwei Zhang, L Polácek, Jens G. Lohr, Molly Schleicher, Emily Lipscomb, Andrea Saltzman, Nelly Oliver, Lori Marini, Adrienne G. Waks, Lauren C. Harshman, Sara M. Tolaney, Eliezer M. Van Allen, Eric P. Winer, Nancy U. Lin, Mari Nakabayashi, Mary‐Ellen Taplin, Cory M. Johannessen, Levi A. Garraway, Todd R. Golub, Jesse S. Boehm, Nikhil Wagle, Gad Getz, J. Christopher Love, Matthew Meyerson - Nature Communications 2017 cited by 1,095

  6. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 3,031

  7. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liying Zhang, Ahmet Zehir, Joseph Vijai, Howard I. Scher, Charles L. Sawyers, Nikolaus Schultz, Philip W. Kantoff, David B. Solit, Mark E. Robson, Eliezer M. Van Allen, Kenneth Offit, Johann S. de Bono, Peter S. Nelson - New England Journal of Medicine 2016 cited by 1,663

  8. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas W. Griffin, Howard I. Scher, Dana E. Rathkopf - New England Journal of Medicine 2012 cited by 2,795

  9. The long tail of oncogenic drivers in prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wassim Abida, Barry S. Taylor, Howard I. Scher, Peter S. Nelson, Johann S. de Bono, Mark A. Rubin, Charles L. Sawyers, Arul M. Chinnaiyan, Nikolaus Schultz, Eliezer M. Van Allen - Nature Genetics 2018 cited by 884

  10. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 cited by 1,354

  11. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2020 cited by 254

  12. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2004 cited by 3,687

  13. Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2018 cited by 383

  14. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

    Authors: , , , , , , , , , , , , , , - The Journal of Urology 2017 cited by 812

  15. Transcriptional mediators of treatment resistance in lethal prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven P. Balk, Himisha Beltran, Orit Rozenblatt–Rosen, Aviv Regev, Asaf Rotem, Mary‐Ellen Taplin, Eliezer M. Van Allen - Nature Medicine 2021 cited by 193

  16. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 591

  17. Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC)

    Authors: , , , , , , , , , , - The Prostate 2018 cited by 198

  18. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline Powers, Raoul S. Concepcion, Daniel W. Lin, Richard C. Wender, James Ryan Mark, Anthony J. Costello, Arthur L. Burnett, Oliver Sartor, William B. Isaacs, Jianfeng Xu, Jeffrey N. Weitzel, Gerald L. Andriole, Himisha Beltran, Alberto Briganti, Lindsey Byrne, Anne Calvaresi, Thenappan Chandrasekar, David Y.T. Chen, Robert B. Den, Albert Dobi, E. David Crawford, James A. Eastham, Scott E. Eggener, Matthew L. Freedman, Marc B. Garnick, Patrick T. Gomella, Nathan Handley, Mark Hurwitz, Joseph K. Izes, R. Jeffrey Karnes, Costas D. Lallas, Lucia R. Languino, Stacy Loeb, Ana María López, Kevin R. Loughlin, Grace Lu‐Yao, S. Bruce Malkowicz, Mark Mann, Patrick Mille, Martin Miner, Todd M. Morgan, José Moreno, Lorelei A. Mucci, Ronald E. Myers, Sarah M. Nielsen, Brock O’Neil, Wayne H. Pinover, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Charles J. Ryan, Howard M. Sandler, Matthew J. Schiewer, Emily Scott, Brittany M. Szymaniak, William Tester, Edouard J. Trabulsi, Neha Vapiwala, Evan Y. Yu, Charnita Zeigler‐Johnson, Leonard G. Gomella - Journal of Clinical Oncology 2020 cited by 279

  19. Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer E. Fairman, Euihye Jung, Kshitij S. Arora, Osman H. Yilmaz, Sonia Cohen, Tatyana Sharova, Gary Chi, Bryanna L. Norden, Yuhui Song, Linda T. Nieman, Leontios Pappas, Aparna R. Parikh, Matthew R. Strickland, Ryan B. Corcoran, Tomas Mustelin, George Eng, Ömer H. Yilmaz, Ursula A. Matulonis, Andrew T. Chan, Steven J. Skates, Bo R. Rueda, Ronny Drapkin, Samuel J. Klempner, Vikram Deshpande, David T. Ting, Michael P. Rout, John LaCava, David R. Walt, Kathleen H. Burns - Cancer Discovery 2023 cited by 85

  20. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aviv Regev, Matthew Meyerson, William C. Hahn, Philip W. Kantoff, Todd R. Golub, Gad Getz, Jesse S. Boehm, J. Christopher Love - Nature Biotechnology 2014 cited by 534

  21. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2010 cited by 1,084

  22. Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael T. Schweizer, Colin C. Pritchard, Stephen J. Salipante, Mary‐Ellen Taplin, Himisha Beltran, Mark A. Rubin, Marcin Cieślik, Dan R. Robinson, E. Heath, Nikolaus Schultz, Joshua Armenia, Wassim Abida, Howard I. Scher, Christopher J. Lord, Alan D. D’Andrea, Charles L. Sawyers, Arul M. Chinnaiyan, Andrea Alimonti, Peter S. Nelson, Charles G. Drake, Eliezer M. Van Allen, Johann S. de Bono - Journal of Clinical Investigation 2018 cited by 209

  23. Tumor fraction in cell-free DNA as a biomarker in prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - JCI Insight 2018 cited by 146

  24. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip W. Kantoff, Raja B. Khauli, Raya Leibowitz‐Amit, Chris Logothetis, Fernando Cotait Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind M’rabti, Declan G. Murphy, Vedang Murthy, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Robert E. Reiter, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Neal D. Shore, Eric J. Small, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Mary-Ellen Taplin, Bertrand Tombal, Levent Türkeri, Inge M. van Oort, A. Zapatero, Aurelius Omlin - European Urology 2020 cited by 395